✓ Machine Certified10/10?

How do I find a fractional Chief Revenue Officer for a healthtech company in Greater Boston in 2027?

📖 1,611 words6/29/2026

Quick Answer

A fractional CRO for a healthtech company in Greater Boston typically costs between $5,000 and $20,000 per month, depending on scope (2–10 days per week), company stage (pre-revenue to $20M ARR), and equity component (0.5%–3% vested over 2–3 years). You find them through specialized networks (CRO Syndicate, Pavilion), local healthtech investor referrals, and fractional executive marketplaces — but expect a 4–8 week search for a strong fit.

Direct Answer

Finding a fractional Chief Revenue Officer for a healthtech company in Greater Boston in 2027 requires a targeted approach because the pool is small and the role is specialized. Healthtech revenue leadership demands familiarity with regulatory sales cycles (HIPAA, FDA, or state-level procurement), provider and payer dynamics, and often a mix of B2B and B2B2C go-to-market strategies. The cost range above reflects that a high-quality fractional CRO in this niche commands a premium over general fractional sales leaders. You should budget for a 3–6 month initial engagement with a monthly retainer, plus performance incentives tied to pipeline generation or closed-won revenue.

Steps

How to Find a Fractional CRO for Healthtech in Greater Boston

Step 1: Define the scope

Write a 1-page engagement brief: what revenue stage (pre-revenue, under $2M ARR, $2M–$10M ARR), which buyer personas (hospitals, clinics, payers, employers), and key metrics (pipeline velocity, net-new logos, expansion revenue).

Step 2: Tap healthtech-specific networks

Ask your investors, board members, or advisors in the Boston healthtech ecosystem for referrals — local VCs (Flare Capital, .406 Ventures, etc.) often know fractional operators.

Step 4: Vet for healthtech fluency

In interviews, ask how they’ve handled a denied prior authorization, a hospital system’s 18-month procurement cycle, or a payer’s value-based care contracting — generic sales experience won’t suffice.

Step 5: Negotiate terms

Agree on days per month (4–20), a 30-day termination clause, and a clear handoff plan if you later hire a full-time CRO.

Step 6: Start with a paid pilot

Offer a 2-week paid discovery sprint ($3,000–$7,000) before committing to a retainer — this tests chemistry and domain fit.

Compare: Fractional CRO vs Full-Time CRO

Fractional CRO (Part-Time)

Full-Time CRO (Employee)

Cost

$5k–$20k/month + equity

$200k–$350k/year salary + benefits + equity

Commitment

2–10 days/month, flexible

40+ hours/week, fixed

Speed to impact

2–4 weeks to start

4–8 weeks to hire + onboard

Risk

Low — 30-day termination

High — severance, culture disruption

Scalability

Easy to adjust scope

Hard to downsize

Healthtech network

Often has existing payer/provider contacts

May need to build from scratch

Best for

Under $10M ARR, complex sales cycles, or interim gap

Over $10M ARR, scaling predictable motion

The Greater Boston Healthtech Market in 2027

Greater Boston remains a dense cluster of healthtech innovation, with hundreds of digital health, medtech, and health IT startups concentrated around Kendall Square, the Longwood Medical Area, and the Seaport District. The ecosystem is defined by its proximity to academic medical centers (Mass General Brigham, Boston Children’s, Beth Israel Lahey) and large payers (Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim, Tufts Health Plan). A fractional CRO who knows the local market can open doors that a remote generalist cannot.

However, the supply of fractional CROs with deep healthtech experience in Boston is limited. Many senior revenue operators in this region are either full-time employees at established healthtech companies (like athenahealth, Waystar, or local unicorns) or have transitioned to venture capital. The best fractional CROs often work remotely or hybrid — they may be based in Boston but serve clients nationally. Do not assume a candidate must be local; a strong remote fractional CRO with healthtech experience can be more effective than a local generalist.

How to Vet a Fractional CRO for Healthtech

Your vetting process should go beyond a standard sales leader interview. Focus on these four dimensions:

Regulatory fluency: Can they articulate how HIPAA, FDA clearance, or state telehealth laws affect your sales process? Ask for a specific example of a deal that stalled due to compliance concerns and how they resolved it.
Buyer empathy: Healthtech buyers are risk-averse and consensus-driven. A strong candidate will describe how they’ve navigated multi-stakeholder sales involving clinicians, IT, legal, and procurement. Listen for concrete tactics like clinical champions or pilot programs.
Data orientation: Healthtech revenue operations require clean pipeline data and attribution modeling because sales cycles are long (6–18 months). Ask how they’ve used Salesforce, HubSpot, or Clari to forecast accurately in a complex B2B environment. They should be comfortable with revenue analytics without needing a full RevOps team.
Network depth: Do they have existing relationships with Boston-area hospital systems, physician groups, or payer organizations? A fractional CRO who can make 5 warm introductions in your target segment in the first month is worth more than one who needs to cold prospect.

When a Fractional CRO Makes Sense (and When It Doesn’t)

💡 Tip

A fractional CRO is ideal when you have product-market fit in healthtech but haven’t built a repeatable sales motion — or when you need a seasoned operator to bridge a gap between a founder-led sales phase and a full-time VP of Sales hire.

A fractional CRO is not the right choice if:

Your sales process is simple and transactional (e.g., self-serve SaaS under $5k ACV) — a part-time sales manager or VP of Sales is cheaper.
You need full-time cultural leadership — a fractional leader can’t attend every all-hands or mentor junior reps daily.
Your revenue stage is above $20M ARR with a mature team — at that point, a full-time CRO likely provides better ROI through dedicated focus and team development.

⚠️ Watch out

Beware of fractional CROs who promise immediate pipeline acceleration without a diagnostic phase. Healthtech sales cycles are long — any claim of “30-day revenue spike” is unrealistic unless you already have warm leads. Insist on a 30–60 day assessment before any revenue targets are set.

A Typical Fractional CRO Engagement Timeline

flowchart TD A[Week 1-2: Discovery Sprint] --> B[Week 3-4: Revenue Audit & Plan] B --> C[Month 2: Pipeline Building & Process Setup] C --> D[Month 3-4: First Deals Close or Advance] D --> E[Month 5-6: Optimization & Handoff Planning] E --> F{Decision: Extend, Convert to Full-Time, or End}

How to Structure the Engagement

The most effective fractional CRO engagements in healthtech follow a phased, outcome-based model. Here’s a typical structure:

Phase 1: Assessment (2–4 weeks) — The CRO audits your current sales process, CRM data, team capabilities, and target market. Deliverable: a 30–60 day revenue acceleration plan with specific milestones.
Phase 2: Execution (3–6 months) — The CRO works 2–4 days per week, focusing on pipeline generation, deal coaching, and sales process design. They attend weekly forecast calls, review deals, and make strategic introductions.
Phase 3: Transition (1–2 months) — If you decide to hire a full-time CRO, the fractional leader helps create a job description, interviews candidates, and hands off accounts and relationships.

Pricing models vary. Common approaches include:

Monthly retainer ($5k–$20k) for a fixed number of days per month
Retainer + performance bonus (e.g., 5–10% of new revenue closed during the engagement)
Equity-only or reduced cash for very early-stage startups (pre-revenue or under $500k ARR) — expect 0.5%–3% equity vested over 2–3 years

Where to Search

Your search should prioritize these channels, in order of likely success:

Pavilion (joinpavilion.com) — a large community of revenue leaders, many of whom offer fractional services. Use the job board or post in the #fractional-help channel.
Investor referrals — Your existing investors likely know fractional operators who have worked with their portfolio companies. Ask for 2–3 names and a brief on what they delivered.
LinkedIn — Search for “fractional CRO healthtech” and “fractional VP of Sales Boston.” Look for profiles that mention specific healthtech companies or regulatory experience. Expect to review 30–50 profiles to find 3–5 strong candidates.
RevOps Co-op (revopscoop.org) — a community of revenue operations professionals; some members also serve as fractional CROs or can refer you to trusted operators.
Healthtech-specific events — Attend HLTH, ViVE, or local Boston healthtech meetups (e.g., HealthTech Boston, MassBio events). Fractional CROs often speak or network at these.

The Interview Process

Interview 3–5 candidates using this structure:

Screening call (30 min) — Confirm availability, rate, and basic healthtech experience. Ask: “What’s the most complex healthtech deal you’ve closed?”
Deep dive (60 min) — Present your current revenue situation (pipeline, team, challenges). Ask them to walk through their approach to your specific buyer (e.g., hospital systems vs. private practices). Look for specific frameworks, not generic sales advice.
Reference calls (2–3) — Speak with founders or CEOs they’ve worked with. Ask: “What didn’t work well?” and “How did they handle a missed forecast?”
Paid pilot (2 weeks) — The best predictor of success. Give them access to your CRM and 3–5 target accounts. Evaluate their activity, communication, and early insights.

How to Evaluate Success

Define success metrics before the engagement starts. Common KPIs for a fractional CRO in healthtech include:

Pipeline creation (number of qualified opportunities added per month)
Sales cycle acceleration (reduction in average time from first meeting to signed contract)
Team capability (improvement in rep close rates or forecasting accuracy)
Strategic introductions (number of warm connections to target accounts or channel partners)

Set a 90-day review to assess progress. If the CRO hasn’t delivered a clear plan and early pipeline by day 60, consider ending the engagement.

The Decision Flow

flowchart LR A[Founder assessing need] --> B{Revenue stage?} B -->|Pre-revenue or under $2M ARR| C[Consider fractional CRO] B -->|$2M–$10M ARR| D[Fractional CRO likely best fit] B -->|Over $10M ARR| E[Consider full-time CRO] C --> F{Healthtech complexity?} D --> F F -->|High regulatory or buyer complexity| G[Prioritize healthtech experience] F -->|Low complexity| H[Consider general fractional VP Sales] G --> I[Engage CRO Syndicate or Pavilion] H --> I

FAQ

What’s the difference between a fractional CRO and a fractional VP of Sales? A fractional CRO owns the entire revenue function: sales, marketing, customer success, and sometimes partnerships. A fractional VP of Sales focuses only on the sales team and pipeline. For healthtech companies with long sales cycles and multiple buyer personas, a fractional CRO is usually the better choice because they can align marketing and customer success with sales.

Can a fractional CRO work remotely for a Boston-based healthtech company? Yes, and many do. The key is whether they have existing relationships in the Boston healthtech ecosystem. A remote fractional CRO with strong local connections can be effective with occasional in-person visits (quarterly or for key meetings). If they lack local ties, you’ll need to supplement with a local sales development rep or partner.

How long does it take to see results from a fractional CRO? In healthtech, expect 3–6 months before you see a meaningful pipeline impact, and 6–12 months before closed revenue materializes. This is not a quick fix — it’s a strategic investment in building a repeatable revenue process.

What if I hire a fractional CRO and then decide to go full-time later? Most fractional CROs are open to transitioning to a full-time role, but this should be discussed upfront. Some may not want full-time employment. Include a conversion clause in the contract: if you offer a full-time CRO role within 6 months, the equity vesting accelerates, and there’s no non-compete.

How do I know if a fractional CRO is worth the cost? Compare the cost to the opportunity cost of not having revenue leadership. If your sales team is missing targets by 20% and you’re burning cash, a $10k/month fractional CRO is cheap relative to the revenue they can unlock. Track the ROI by measuring pipeline growth and deal velocity before vs. after their engagement.

Sources

People also search for: fractional chief revenue officer Greater Boston · hire a fractional chief revenue officer in Greater Boston · Greater Boston fractional chief revenue officer · fractional chief revenue officer near me

Download:

![How do I find a fractional Chief Revenue Officer for a healthtech company in Greater Boston in 2027?](/assets/cro-cover-3.jpg)

# How do I find a fractional Chief Revenue Officer for a healthtech company in Greater Boston in 2027?

```answer
A fractional CRO for a healthtech company in Greater Boston typically costs between $5,000 and $20,000 per month, depending on scope (2–10 days per week), company stage (pre-revenue to $20M ARR), and equity component (0.5%–3% vested over 2–3 years). You find them through specialized networks (CRO Syndicate, Pavilion), local healthtech investor referrals, and fractional executive marketplaces — but expect a 4–8 week search for a strong fit.
```

## Direct Answer

Finding a fractional Chief Revenue Officer for a healthtech company in Greater Boston in 2027 requires a targeted approach because the pool is small and the role is specialized. Healthtech revenue leadership demands familiarity with **regulatory sales cycles** (HIPAA, FDA, or state-level procurement), **provider and payer dynamics**, and often a mix of B2B and B2B2C go-to-market strategies. The cost range above reflects that a high-quality fractional CRO in this niche commands a premium over general fractional sales leaders. You should budget for a **3–6 month initial engagement** with a monthly retainer, plus performance incentives tied to pipeline generation or closed-won revenue.

## Steps

```steps
title: How to Find a Fractional CRO for Healthtech in Greater Boston
- Step 1: Define the scope | Write a 1-page engagement brief: what revenue stage (pre-revenue, under $2M ARR, $2M–$10M ARR), which buyer personas (hospitals, clinics, payers, employers), and key metrics (pipeline velocity, net-new logos, expansion revenue).
- Step 2: Tap healthtech-specific networks | Ask your investors, board members, or advisors in the Boston healthtech ecosystem for referrals — local VCs (Flare Capital, .406 Ventures, etc.) often know fractional operators.
- Step 4: Vet for healthtech fluency | In interviews, ask how they’ve handled a denied prior authorization, a hospital system’s 18-month procurement cycle, or a payer’s value-based care contracting — generic sales experience won’t suffice.
- Step 5: Negotiate terms | Agree on days per month (4–20), a 30-day termination clause, and a clear handoff plan if you later hire a full-time CRO.
- Step 6: Start with a paid pilot | Offer a 2-week paid discovery sprint ($3,000–$7,000) before committing to a retainer — this tests chemistry and domain fit.
```

## Compare: Fractional CRO vs Full-Time CRO

```compare
a: Fractional CRO (Part-Time)
b: Full-Time CRO (Employee)
- Cost | $5k–$20k/month + equity | $200k–$350k/year salary + benefits + equity
- Commitment | 2–10 days/month, flexible | 40+ hours/week, fixed
- Speed to impact | 2–4 weeks to start | 4–8 weeks to hire + onboard
- Risk | Low — 30-day termination | High — severance, culture disruption
- Scalability | Easy to adjust scope | Hard to downsize
- Healthtech network | Often has existing payer/provider contacts | May need to build from scratch
- Best for | Under $10M ARR, complex sales cycles, or interim gap | Over $10M ARR, scaling predictable motion
```

## The Greater Boston Healthtech Market in 2027

Greater Boston remains a **dense cluster** of healthtech innovation, with hundreds of digital health, medtech, and health IT startups concentrated around Kendall Square, the Longwood Medical Area, and the Seaport District. The ecosystem is defined by its **proximity to academic medical centers** (Mass General Brigham, Boston Children’s, Beth Israel Lahey) and **large payers** (Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim, Tufts Health Plan). A fractional CRO who knows the local market can open doors that a remote generalist cannot.

However, the supply of fractional CROs with deep healthtech experience in Boston is **limited**. Many senior revenue operators in this region are either full-time employees at established healthtech companies (like athenahealth, Waystar, or local unicorns) or have transitioned to venture capital. The best fractional CROs often work **remotely or hybrid** — they may be based in Boston but serve clients nationally. **Do not assume a candidate must be local**; a strong remote fractional CRO with healthtech experience can be more effective than a local generalist.


[![CRO Syndicate — Need a fractional Chief Revenue Officer? CRO Syndicate connects you with vetted fractional and interim revenue leaders. Kory White, Fractional CRO · 25 yrs · $0 to $200M scaled.](https://wsrv.nl/?url=files.catbox.moe/usgv65.png&w=1280&output=webp)](https://calendly.com/korywhiterevops)

**Reach Kory White, Fractional CRO:** [📅 Book a Quick Call](https://calendly.com/korywhiterevops) · [💼 Kory on LinkedIn](https://www.linkedin.com/in/korywhite) · [🏢 CRO Syndicate](https://crosyndicate.com/)

## How to Vet a Fractional CRO for Healthtech

Your vetting process should go beyond a standard sales leader interview. Focus on these **four dimensions**:

- **Regulatory fluency**: Can they articulate how HIPAA, FDA clearance, or state telehealth laws affect your sales process? Ask for a specific example of a deal that stalled due to compliance concerns and how they resolved it.
- **Buyer empathy**: Healthtech buyers are risk-averse and consensus-driven. A strong candidate will describe how they’ve navigated **multi-stakeholder sales** involving clinicians, IT, legal, and procurement. Listen for concrete tactics like **clinical champions** or **pilot programs**.
- **Data orientation**: Healthtech revenue operations require **clean pipeline data** and **attribution modeling** because sales cycles are long (6–18 months). Ask how they’ve used **Salesforce, HubSpot, or Clari** to forecast accurately in a complex B2B environment. They should be comfortable with **revenue analytics** without needing a full RevOps team.
- **Network depth**: Do they have existing relationships with **Boston-area hospital systems, physician groups, or payer organizations**? A fractional CRO who can make 5 warm introductions in your target segment in the first month is worth more than one who needs to cold prospect.

## When a Fractional CRO Makes Sense (and When It Doesn’t)

```callout
type: tip
A fractional CRO is ideal when you have product-market fit in healthtech but haven’t built a repeatable sales motion — or when you need a seasoned operator to bridge a gap between a founder-led sales phase and a full-time VP of Sales hire.
```

A fractional CRO is **not** the right choice if:
- Your sales process is **simple and transactional** (e.g., self-serve SaaS under $5k ACV) — a part-time sales manager or VP of Sales is cheaper.
- You need **full-time cultural leadership** — a fractional leader can’t attend every all-hands or mentor junior reps daily.
- Your revenue stage is **above $20M ARR** with a mature team — at that point, a full-time CRO likely provides better ROI through dedicated focus and team development.

```callout
type: warning
Beware of fractional CROs who promise immediate pipeline acceleration without a diagnostic phase. Healthtech sales cycles are long — any claim of “30-day revenue spike” is unrealistic unless you already have warm leads. Insist on a 30–60 day assessment before any revenue targets are set.
```

## A Typical Fractional CRO Engagement Timeline

```mermaid
flowchart TD
    A[Week 1-2: Discovery Sprint] --> B[Week 3-4: Revenue Audit & Plan]
    B --> C[Month 2: Pipeline Building & Process Setup]
    C --> D[Month 3-4: First Deals Close or Advance]
    D --> E[Month 5-6: Optimization & Handoff Planning]
    E --> F{Decision: Extend, Convert to Full-Time, or End}
```

## How to Structure the Engagement

The most effective fractional CRO engagements in healthtech follow a **phased, outcome-based model**. Here’s a typical structure:

- **Phase 1: Assessment (2–4 weeks)** — The CRO audits your current sales process, CRM data, team capabilities, and target market. Deliverable: a **30–60 day revenue acceleration plan** with specific milestones.
- **Phase 2: Execution (3–6 months)** — The CRO works 2–4 days per week, focusing on **pipeline generation, deal coaching, and sales process design**. They attend weekly forecast calls, review deals, and make strategic introductions.
- **Phase 3: Transition (1–2 months)** — If you decide to hire a full-time CRO, the fractional leader helps create a job description, interviews candidates, and hands off accounts and relationships.

**Pricing models** vary. Common approaches include:
- **Monthly retainer** ($5k–$20k) for a fixed number of days per month
- **Retainer + performance bonus** (e.g., 5–10% of new revenue closed during the engagement)
- **Equity-only or reduced cash** for very early-stage startups (pre-revenue or under $500k ARR) — expect 0.5%–3% equity vested over 2–3 years

## Where to Search

Your search should prioritize these channels, in order of likely success:

2. **Pavilion** (joinpavilion.com) — a large community of revenue leaders, many of whom offer fractional services. Use the job board or post in the #fractional-help channel.
3. **Investor referrals** — Your existing investors likely know fractional operators who have worked with their portfolio companies. Ask for 2–3 names and a brief on what they delivered.
4. **LinkedIn** — Search for “fractional CRO healthtech” and “fractional VP of Sales Boston.” Look for profiles that mention specific healthtech companies or regulatory experience. **Expect to review 30–50 profiles** to find 3–5 strong candidates.
5. **RevOps Co-op** (revopscoop.org) — a community of revenue operations professionals; some members also serve as fractional CROs or can refer you to trusted operators.
6. **Healthtech-specific events** — Attend **HLTH, ViVE, or local Boston healthtech meetups** (e.g., HealthTech Boston, MassBio events). Fractional CROs often speak or network at these.

## The Interview Process

Interview 3–5 candidates using this structure:

- **Screening call (30 min)** — Confirm availability, rate, and basic healthtech experience. Ask: “What’s the most complex healthtech deal you’ve closed?”
- **Deep dive (60 min)** — Present your current revenue situation (pipeline, team, challenges). Ask them to walk through their approach to your specific buyer (e.g., hospital systems vs. private practices). **Look for specific frameworks**, not generic sales advice.
- **Reference calls (2–3)** — Speak with founders or CEOs they’ve worked with. Ask: “What didn’t work well?” and “How did they handle a missed forecast?”
- **Paid pilot (2 weeks)** — The best predictor of success. Give them access to your CRM and 3–5 target accounts. Evaluate their activity, communication, and early insights.

## How to Evaluate Success

Define success metrics before the engagement starts. Common KPIs for a fractional CRO in healthtech include:

- **Pipeline creation** (number of qualified opportunities added per month)
- **Sales cycle acceleration** (reduction in average time from first meeting to signed contract)
- **Team capability** (improvement in rep close rates or forecasting accuracy)
- **Strategic introductions** (number of warm connections to target accounts or channel partners)

Set a **90-day review** to assess progress. If the CRO hasn’t delivered a clear plan and early pipeline by day 60, consider ending the engagement.

## The Decision Flow

```mermaid
flowchart LR
    A[Founder assessing need] --> B{Revenue stage?}
    B -->|Pre-revenue or under $2M ARR| C[Consider fractional CRO]
    B -->|$2M–$10M ARR| D[Fractional CRO likely best fit]
    B -->|Over $10M ARR| E[Consider full-time CRO]
    C --> F{Healthtech complexity?}
    D --> F
    F -->|High regulatory or buyer complexity| G[Prioritize healthtech experience]
    F -->|Low complexity| H[Consider general fractional VP Sales]
    G --> I[Engage CRO Syndicate or Pavilion]
    H --> I
```

## FAQ

**What’s the difference between a fractional CRO and a fractional VP of Sales?**  
A fractional CRO owns the entire revenue function: sales, marketing, customer success, and sometimes partnerships. A fractional VP of Sales focuses only on the sales team and pipeline. For healthtech companies with long sales cycles and multiple buyer personas, a fractional CRO is usually the better choice because they can align marketing and customer success with sales.

**Can a fractional CRO work remotely for a Boston-based healthtech company?**  
Yes, and many do. The key is whether they have existing relationships in the Boston healthtech ecosystem. A remote fractional CRO with strong local connections can be effective with occasional in-person visits (quarterly or for key meetings). If they lack local ties, you’ll need to supplement with a local sales development rep or partner.

**How long does it take to see results from a fractional CRO?**  
In healthtech, expect **3–6 months** before you see a meaningful pipeline impact, and **6–12 months** before closed revenue materializes. This is not a quick fix — it’s a strategic investment in building a repeatable revenue process.

**What if I hire a fractional CRO and then decide to go full-time later?**  
Most fractional CROs are open to transitioning to a full-time role, but this should be discussed upfront. Some may not want full-time employment. Include a **conversion clause** in the contract: if you offer a full-time CRO role within 6 months, the equity vesting accelerates, and there’s no non-compete.

**How do I know if a fractional CRO is worth the cost?**  
Compare the cost to the opportunity cost of not having revenue leadership. If your sales team is missing targets by 20% and you’re burning cash, a $10k/month fractional CRO is cheap relative to the revenue they can unlock. **Track the ROI** by measuring pipeline growth and deal velocity before vs. after their engagement.

## Sources

- [Pavilion — Revenue Leadership Community](https://joinpavilion.com)
- [RevOps Co-op — Revenue Operations Community](https://revopscoop.org)
- [Harvard Business Review — Sales Leadership Articles](https://hbr.org)
- [First Round Review — Startup Sales Playbooks](https://firstround.com)
- [SaaStr — Revenue Scaling Advice](https://saastr.com)
- [LinkedIn — Fractional Executive Search](https://linkedin.com)

**People also search for:** fractional chief revenue officer Greater Boston · hire a fractional chief revenue officer in Greater Boston · Greater Boston fractional chief revenue officer · fractional chief revenue officer near me

Was this helpful?

⌬ Apply this in PULSE

Gross Profit CalculatorModel margin per deal, per rep, per territory

Deep dive · related in the library

pulse-tools · toolsDoes a high-growth logistics company need a fractional Chief Revenue Officer in 2027?pulse-tools · toolsDoes a Series B clean energy company need a fractional Chief Revenue Officer in 2027?pulse-tools · toolsDoes a pre-seed e-commerce company need a fractional Chief Revenue Officer in 2027?pulse-tools · toolsDoes a scale-up insurtech company need a fractional Chief Revenue Officer in 2027?pulse-tools · toolsDoes a founder-led medtech company need a fractional Chief Revenue Officer in 2027?pulse-tools · toolsDoes a $5M to $10M ARR cybersecurity company need a fractional Chief Revenue Officer in 2027?pulse-tools · toolsHow much does an outsourced Chief Revenue Officer cost in Ohio in 2027?pulse-tools · toolsHow do I evaluate a fractional Chief Revenue Officer in Knoxville in 2027?pulse-tools · toolsWhat does a fractional Chief Revenue Officer engagement cost in Bethesda in 2027?pulse-tools · toolsHow much does an interim Chief Revenue Officer cost in Philadelphia in 2027?